Cargando…

Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, M(pro) and PL(pro) of SARS-CoV-2: Protein–Protein Interactions, Dynamics Simulations and Free Energy Calculations

The emergence of COVID-19 continues to pose severe threats to global public health. The pandemic has infected over 171 million people and claimed more than 3.5 million lives to date. We investigated the binding potential of antiviral cyanobacterial proteins including cyanovirin-N, scytovirin and phy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naidoo, Devashan, Kar, Pallab, Roy, Ayan, Mutanda, Taurai, Bwapwa, Joseph, Sen, Arnab, Anandraj, Akash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434238/ https://www.ncbi.nlm.nih.gov/pubmed/34500548 http://dx.doi.org/10.3390/molecules26175114

Ejemplares similares

Discovery of PL(pro) and M(pro) Inhibitors for SARS-CoV-2
por: Puhl, Ana C., et al.
Publicado: (2023)

An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development
por: Lotfi, Hajie, et al.
Publicado: (2018)

An overview of potential inhibitors targeting non-structural proteins 3 (PL(pro) and Mac1) and 5 (3CL(pro)/M(pro)) of SARS-CoV-2
por: Yan, Fangfang, et al.
Publicado: (2021)

Design of fusion protein for efficient preparation of cyanovirin-n and rapid enrichment of pseudorabies virus
por: Wang, Bin, et al.
Publicado: (2021)

“Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CL(pro) and PL(pro)"
por: Bhowmik, Deep, et al.
Publicado: (2021)

Spatial and temporal roles of SARS‐CoV PL(pro)—A snapshot
por: Yan, Shaomin, et al.
Publicado: (2020)

SARS-CoV-PL(pro)-Inhibitoren als mögliche Breitspektrum-Virostatika
por: Hammerschmidt, Stefan Josef, et al.
Publicado: (2021)

Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL(pro) and PL(pro)), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)
por: Mouffouk, Chaima, et al.
Publicado: (2021)

Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL(PRO) and 3CL(PRO) proteases
por: Jade, Dhananjay, et al.
Publicado: (2021)

In silico study of natural compounds from sesame against COVID-19 by targeting M(pro), PL(pro) and RdRp
por: Allam, Ahmed E., et al.
Publicado: (2021)

Development of 2-chloroquinoline based heterocyclic frameworks as dual inhibitors of SARS-CoV-2 M(Pro) and PL(Pro)
por: Kattula, Bhavita, et al.
Publicado: (2023)

Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PL(pro) and M(pro) proteases, and nsp14 guanine N7-methyltransferase
por: Zmudzinski, Mikolaj, et al.
Publicado: (2023)

FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 M(pro) and PL(pro)
por: Tan, Haozhou, et al.
Publicado: (2023)

In Silico and In Vitro Inhibition of SARS-CoV-2 PL(pro) with Gramicidin D
por: Protić, Sara, et al.
Publicado: (2023)

Pro-resolving and anti-arthritic properties of the MC(1) selective agonist PL8177
por: Garrido-Mesa, Jose, et al.
Publicado: (2022)

A Designed “Nested” Dimer of Cyanovirin-N Increases Antiviral Activity
por: Woodrum, Brian W., et al.
Publicado: (2016)

Development of a Graphene-Based Biosensor for Detecting Recombinant Cyanovirin-N
por: de Almeida, Pedro Rodrigues, et al.
Publicado: (2020)

Virtual screening based on the structure of more than 10(5) compounds against four key proteins of SARS-CoV-2: M(Pro), S(RBD), RdRp, and PL(pro)
por: Nabati, Farzan, et al.
Publicado: (2022)

Diphenyl Diselenide and SARS-CoV-2: in silico Exploration of the Mechanisms of Inhibition of Main Protease (M(pro)) and Papain-like Protease (PL(pro))
por: Omage, Folorunsho Bright, et al.
Publicado: (2023)

Cyanovirin-N Binds Viral Envelope Proteins at the Low-Affinity Carbohydrate Binding Site without Direct Virus Neutralization Ability
por: Maier, Irene, et al.
Publicado: (2021)

ProTherm and ProNIT: thermodynamic databases for proteins and protein–nucleic acid interactions
por: Kumar, M. D. Shaji, et al.
Publicado: (2006)

Dual targeting of 3CL(pro) and PL(pro) of SARS-CoV-2: A novel structure-based design approach to treat COVID-19
por: Rajpoot, Sajjan, et al.
Publicado: (2020)

Effects of diarylbutane lignans from Schisandra chinensis fruit on SARS-CoV-2 3CL(pro) and PL(pro) and their in vitro anti-inflammatory properties
por: Li, Bin, et al.
Publicado: (2023)

MERS‐CoV papain-like protease (PL(pro)): expression, purification, and spectroscopic/thermodynamic characterization
por: Malik, Ajamaluddin, et al.
Publicado: (2017)

Potential COVID-19 papain-like protease PL(pro) inhibitors: repurposing FDA-approved drugs
por: Kouznetsova, Valentina L., et al.
Publicado: (2020)

The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650
por: Su, Qiu-dong, et al.
Publicado: (2020)

Expression, purification and analysis of the anti-HIV Cyanovirin-N produced in transgenic soybeans seeds
por: Murad, Andre, et al.
Publicado: (2014)

Design of novel cyanovirin-N variants by modulation of binding dynamics through distal mutations
por: Kazan, I Can, et al.
Publicado: (2022)

Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL(pro) and M(pro)/ 3CL(pro): molecular docking and simulation studies of three pertinent medicinal plant natural components
por: Verma, Devvret, et al.
Publicado: (2021)

Perspectives on the probiotic potential of lactic acid bacteria from African traditional fermented foods and beverages
por: Mokoena, Mduduzi Paul, et al.
Publicado: (2016)

In silico studies of M(pro) and PL(pro) from SARS-CoV-2 and a new class of cephalosporin drugs containing 1,2,4-thiadiazole
por: Delgado, Cássia Pereira, et al.
Publicado: (2022)

Schaftoside inhibits 3CL(pro) and PL(pro) of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19
por: Yi, Yang, et al.
Publicado: (2022)

The representation of protein complexes in the Protein Ontology (PRO)
por: Bult, Carol J, et al.
Publicado: (2011)

Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2
por: Muñoz-Basagoiti, Jordana, et al.
Publicado: (2023)

Soluble cytoplasmic expression, rapid purification, and characterization of cyanovirin-N as a His-SUMO fusion
por: Gao, Xianglei, et al.
Publicado: (2009)

Mannosylated hemagglutinin peptides bind cyanovirin-N independent of disulfide-bonds in complementary binding sites
por: Schilling, Philipp E., et al.
Publicado: (2020)

3CL(pro) and PL(pro) affinity, a docking study to fight COVID19 based on 900 compounds from PubChem and literature. Are there new drugs to be found?
por: Štekláč, Marek, et al.
Publicado: (2021)

Oligosaccharides production from coprophilous fungi: An emerging functional food with potential health-promoting properties
por: Ojwach, Jeff, et al.
Publicado: (2022)

ProCoS: Protein composition server
por: Rishishwar, Lavanya, et al.
Publicado: (2010)

LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus
por: Gramberg, Thomas, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_prno3pca9orhmnv0mft0h5fsrg